Literature DB >> 15169903

RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Steven P Angus1, Christopher N Mayhew, David A Solomon, Wesley A Braden, Michael P Markey, Yukiko Okuno, M Cristina Cardoso, David M Gilbert, Erik S Knudsen.   

Abstract

The retinoblastoma (RB) tumor suppressor is a critical negative regulator of cellular proliferation. Repression of E2F-dependent transcription has been implicated as the mechanism through which RB inhibits cell cycle progression. However, recent data have suggested that the direct interaction of RB with replication factors or sites of DNA synthesis may contribute to its ability to inhibit S phase. Here we show that RB does not exert a cis-acting effect on DNA replication. Furthermore, the localization of RB was distinct from replication foci in proliferating cells. While RB activation strongly attenuated the RNA levels of multiple replication factors, their protein expression was not diminished coincident with cell cycle arrest. During the first 24 h of RB activation, components of the prereplication complex, initiation factors, and the clamp loader complex (replication factor C) remained tethered to chromatin. In contrast, the association of PCNA and downstream components of the processive replication machinery was specifically disrupted. This signaling from RB occurred in a manner dependent on E2F-mediated transcriptional repression. Following long-term activation of RB, we observed the attenuation of multiple replication factors, the complete cessation of DNA synthesis, and impaired replicative capacity in vitro. Therefore, functional distinctions exist between the "chronic" RB-mediated arrest state and the "acute" arrest state. Strikingly, attenuation of RB activity reversed both acute and chronic replication blocks. Thus, continued RB action is required for the maintenance of two kinetically and functionally distinct modes of replication inhibition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15169903      PMCID: PMC419877          DOI: 10.1128/MCB.24.12.5404-5420.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Proliferation of cancer cells despite CDK2 inhibition.

Authors:  Osamu Tetsu; Frank McCormick
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

2.  Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage.

Authors:  Dror Avni; Hong Yang; Fabio Martelli; Francesco Hofmann; Wael M ElShamy; Shridar Ganesan; Ralph Scully; David M Livingston
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

Review 3.  Emerging roles for E2F: beyond the G1/S transition and DNA replication.

Authors:  Hugh Cam; Brian David Dynlacht
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

4.  Cyclin E ablation in the mouse.

Authors:  Yan Geng; Qunyan Yu; Ewa Sicinska; Manjusri Das; Jürgen E Schneider; Shoumo Bhattacharya; William M Rideout; Roderick T Bronson; Humphrey Gardner; Piotr Sicinski
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

5.  A role for Ran-GTP and Crm1 in blocking re-replication.

Authors:  Ryuji Yamaguchi; John Newport
Journal:  Cell       Date:  2003-04-04       Impact factor: 41.582

Review 6.  How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein.

Authors:  David W Goodrich
Journal:  J Cell Physiol       Date:  2003-11       Impact factor: 6.384

7.  Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

Authors:  Sagrario Ortega; Ignacio Prieto; Junko Odajima; Alberto Martín; Pierre Dubus; Rocio Sotillo; Jose Luis Barbero; Marcos Malumbres; Mariano Barbacid
Journal:  Nat Genet       Date:  2003-08-17       Impact factor: 38.330

8.  RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult.

Authors:  Emily E Bosco; Christopher N Mayhew; Robert F Hennigan; Julien Sage; Tyler Jacks; Erik S Knudsen
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

9.  Retinoblastoma tumor suppressor: analyses of dynamic behavior in living cells reveal multiple modes of regulation.

Authors:  Steven P Angus; David A Solomon; Lioba Kuschel; Robert F Hennigan; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

View more
  17 in total

1.  cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.

Authors:  Soheil Naderi; Jean Y J Wang; Tung-Ti Chen; Kristine B Gutzkow; Heidi K Blomhoff
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

2.  CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression.

Authors:  Feng Liu; Wen-Hwa Lee
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 3.  Proapoptotic role of novel gene-expression factors.

Authors:  J V Tapia-Vieyra; P Ostrosky-Wegman; J Mas-Oliva
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.405

4.  A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest.

Authors:  S P Angus; J R Nevins
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

5.  Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation.

Authors:  Seda Ghazaryan; Chandler Sy; Tinghui Hu; Xiuli An; Narla Mohandas; Haiqing Fu; Mirit I Aladjem; Victor T Chang; Rene Opavsky; Lizhao Wu
Journal:  Mol Cell Biol       Date:  2014-05-27       Impact factor: 4.272

6.  The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.

Authors:  Sergiy I Borysov; Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

Review 7.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

8.  Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression.

Authors:  Wesley A Braden; Jon M Lenihan; Zhengdao Lan; K Scott Luce; William Zagorski; Emily Bosco; Michael F Reed; Jeanette G Cook; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

9.  Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication.

Authors:  Wasia Rizwani; Mark Alexandrow; Srikumar Chellappan
Journal:  Cell Cycle       Date:  2009-05-27       Impact factor: 4.534

10.  Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway.

Authors:  E E Hoskins; R W Gunawardena; K B Habash; T M Wise-Draper; M Jansen; E S Knudsen; S I Wells
Journal:  Oncogene       Date:  2008-04-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.